Gül Başaran
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 30
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 8
- Vascular Tumors and Angiosarcomas 4
- Cancer Risks and Factors 3
- COVID-19 and healthcare impacts 3
-
- Advanced Breast Cancer Therapies 8
- Co-authors
- Martine Piccart (4 shared papers)Perran Fulden Yumuk (19 shared papers)Faysal Dane (13 shared papers)George W. Sledge (2 shared papers)Marc Buyse (2 shared papers)Jean‐Marc Nabholtz (2 shared papers)Jacek Jassem (2 shared papers)Hans‐Joachim Lück (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Medical Oncology (3 papers)Cancers (2 papers)The Breast (2 papers)ESMO Open (2 papers)
- Partner nations
- TürkiyeUnited KingdomBelgium
In The Last Decade
Gül Başaran
44 papers receiving 932 citations
Peers
Comparison fields: 5 of 74
- Oncology 457
- Cancer Research 195
- Statistics and Probability 58
- Emergency Medical Services 41
- Pulmonary and Respiratory Medicine 160
Countries citing papers authored by Gül Başaran
This map shows the geographic impact of Gül Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gül Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gül Başaran more than expected).
Fields of papers citing papers by Gül Başaran
This network shows the impact of papers produced by Gül Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gül Başaran. The network helps show where Gül Başaran may publish in the future.
Co-authors
The 25 scholars most cited alongside Gül Başaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 269 | |
| 2 | 2008 | 165 | |
| 3 | HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. | 2006 | 89 |
| 4 | 2009 | 49 | |
| 5 | 2009 | 43 | |
| 6 | 2007 | 42 | |
| 7 | 2015 | 38 | |
| 8 | 2015 | 33 | |
| 9 | 2007 | 31 | |
| 10 | 2017 | 27 | |
| 11 | 2010 | 21 | |
| 12 | 2010 | 19 | |
| 13 | Impact of body mass index on cancer development. | 2008 | 12 |
| 14 | 2012 | 11 | |
| 15 | 2007 | 11 | |
| 16 | 2014 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2009 | 8 | |
| 19 | 2021 | 6 | |
| 20 | 2022 | 6 |
About Gül Başaran
Gül Başaran is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 52 papers that have together received 960 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (8 papers), Lymphoma Diagnosis and Treatment (4 papers), Vascular Tumors and Angiosarcomas (4 papers), Cancer Risks and Factors (3 papers) and COVID-19 and healthcare impacts (3 papers). The work is most often cited by research in Oncology (457 citations), Cancer Research (195 citations), Statistics and Probability (58 citations), Emergency Medical Services (41 citations) and Pulmonary and Respiratory Medicine (160 citations). Gül Başaran has collaborated with scholars based in Türkiye, United Kingdom and Belgium. Frequent co-authors include Martine Piccart, Perran Fulden Yumuk, Faysal Dane, George W. Sledge, Marc Buyse, Jean‐Marc Nabholtz, Jacek Jassem, Hans‐Joachim Lück, Laura Biganzoli and James Carmichael. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, Cancers, The Breast and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.